AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Automated Suturing Devices Market to Reach US$ 867.3 Million by 2027 – Coherent Market Insights

December 18, 2019 GMT

SEATTLE--(BUSINESS WIRE)--Dec 18, 2019--

The global automated suturing devices market was valued at US$ 867.3 million in 2027, and is projected to exhibit a CAGR of 5.3 % over the forecast period (2019-2027).

Automated suturing devices are used for closing surgical wounds in order to avoid infection. Hand suturing is a challenging technique and is time consuming. Such scenario has led to R&D in automated suturing devices that are easily manageable, permitting an all-purpose, cost-efficient, and secure suturing.

Statistics:

The global automated suturing devices is estimated to account for US$ 574.1 Mn in terms of value and 5,293,965 Units in terms of volume by the end of 2019.

Request your Sample copy @ https://www.coherentmarketinsights.com/insight/request-sample/3150

Market Drivers

Patients undergoing laparoscopic surgeries prefer automated suturing devices as these devices offer adequate tension throughout the length of the suture, which enables rapid healing and reduces scarring after laparoscopic surgery. Therefore, increasing number of laparoscopic surgeries is expected to boost growth of the global automated suturing devices market over the forecast period. For instance, according to the study, ‘Trends in laparoscopic colorectal surgery over time from 2005-2014 using the NSQIP database’, published in the Journal of Surgical Research in March 2018, during 2005- 2014, the number of colorectal cases increased from 3114 in 2005 to 51,611 in 2014 and a total of 277,376 colorectal cases were identified, of which, 114,359 were performed laparoscopically.

Use of automated suturing devices enables surgeons to achieve accuracy and precision. Moreover, procurement teams at hospitals also prefer these devices as they are labelled under “green products”, resulting in considerably less impact on the environment as compared to plastic single-use disposable suturing devices. Suturing using automated suturing devices reduces time patients spend in the operating room.

Key Takeaways:

In December 2019, Advanced Medical Solutions Group plc., a developer and manufacturer of tissue adhesives, sutures, haemostats, and internal fixation devices, announced acquisition of Biomatlante, a developer of synthetic bone graft technologies.

In September 2019, Apollo Endosurgery, Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Polypropylene Suture-Anchor Assembly for use specifically with the OverStitch Endoscopic Suturing Systems.

In June 2018, Apollo Endosurgery, Inc. received Special 510(k) clearance from the U.S. Food and Drug Administration for OverStitch Sx Endoscopic Suturing System. The OverStitch and OverStitch Sx endoscopic suturing systems allow physicians to place full-thickness sutures from a flexible endoscope in endoscopic surgery.

Market Trends

Key players in the market are focused on using 3D printing technology for product development. For instance, in January 2018, Sutrue, a UK-based medical technology company, launched its new 3D printed automated suturing devices at The Design Museum, London.

The use of diode lasers in the treatment of mucocele in pediatric patients is increasing in the recent past. Diode lasers offer an effective, rapid, simple, bloodless and well accepted procedure for treating mucocele in pediatric patients. The approach does not lead to bleeding during or after the procedure and no suturing is required. Such developments are expected to hinder growth of the market over the forecast period.

Competitive Landscape

Major players operating in the global automated suturing devices market include, Medtronic Plc., Boston Scientific, C. R. Bard, Inc., Apollo Endosurgery, EndoEvolution, LLC, LSI Solutions, Inc., Baxter International, Inc., and SuturTek Inc.

Key Developments

Orthocell Ltd., a provider of tissue repair and regeneration solutions based in Australia, received confirmation from the U.S. Food and Drug Administration (FDA) that its nerve repair study that is testing CelGro’s efficacy in restoring function to damaged nerves and paralyzed muscles, meets U.S. 510(k) submission requirements. CelGro can assist surgeons with performing complex reconstructive surgical procedures and overcomes the disadvantages of suturing.

In December 2019, The Kawartha Lakes Health Care Initiative (KLHCI) hosted the third annual Rural Medicine Community Experience Day where participated in hands-on workshops in suturing and intubation.

Buy this Report (Single User License) @ https://www.coherentmarketinsights.com/insight/buy-now/3150

Market Segmentation:

 

View source version on businesswire.com:https://www.businesswire.com/news/home/20191218005534/en/

CONTACT: Mr. Raj Shah

Coherent Market Insights

1001 4th Ave.

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email:sales@coherentmarketinsights.com

KEYWORD: UNITED STATES NORTH AMERICA WASHINGTON

INDUSTRY KEYWORD: GENERAL HEALTH HEALTH MEDICAL DEVICES

SOURCE: Coherent Market Insights

Copyright Business Wire 2019.

PUB: 12/18/2019 11:03 AM/DISC: 12/18/2019 11:03 AM

http://www.businesswire.com/news/home/20191218005534/en